Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Biomed Research International|May 22, 2018
Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine TumorsMin Jeong Kim, Mi Jung Kwon, Ho Suk Kang, et al.
Pathology, Research and Practice|February 19, 2017
Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancersMi Jung Kwon, Jeong Won Kim, Jang Yong Jeon, et al.
Human Pathology|April 11, 2018
Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transitionMi Jung Kwon, Young-Soo Rho, Eun Sook Nam, et al.
European Journal of Haematology|February 18, 2015
TCL1 expression predicts overall survival in patients with mantle cell lymphomaSu-Jin Shin, Jin Roh, Hee Jeong Cha, et al.
Pathology, Research and Practice|December 25, 2018
Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancerHong Kyu Lee, Mi Jung Kwon, Jinwon Seo, et al.
Pathology, Research and Practice|October 22, 2019
BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysisKyueng-Whan Min, Ji-Young Choe, Mi Jung Kwon, et al.
Human Pathology|March 22, 2016
Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic valueMi Jung Kwon, Jeong Won Kim, Jae Pil Jung, et al.
Diagnostic Pathology|October 15, 2020
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinomaHong Kyu Lee, Mi Jung Kwon, Yong Joon Ra, et al.
Human Pathology|March 10, 2019
Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targetsHa Young Park, Mi Jung Kwon, Ho Suk Kang, et al.
Cancer Research and Treatment|February 5, 2015
The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by LymphomaHo Young Kim, Ju-Seok Kim, Dae Ro Choi, et al.
Pageof 6